Phospho-EIF4G1 (Ser1232) Antibody

What is Phospho-EIF4G1 (Ser1232) and why is it important in translation regulation?

EIF4G1 functions as a scaffolding protein within the eIF4F complex, which is indispensable for cap-dependent protein translation. The protein provides docking sites for the assembly of eIF4A and eIF4E, binding to the cap structure of mRNA and stabilizing all proteins in the complex . Phosphorylation at specific serine residues, including Ser1232, plays a crucial role in regulating the activity of this complex during normal cellular function and under stress conditions. This phosphorylation site belongs to the IDL (interdomain linker) domain and is specifically targeted by the ERK1/2 signaling pathway, making it an important regulatory point during mitogenic signal transduction . Understanding the dynamics of eIF4G1 phosphorylation provides valuable insights into the molecular mechanisms controlling protein synthesis under various physiological and pathological conditions.

What is the discrepancy between Ser1231 and Ser1232 designations in the literature?

The numbering discrepancy observed between Ser1231 and Ser1232 stems from reference sequence variations in the scientific literature. This mismatch occurs due to different human eIF4G1 sequence references being used - some studies reference a human eIF4G1 sequence containing 1600 amino acids, while others use the canonical sequence (Q04637-1) with 1599 amino acids . Therefore, when comparing research findings across different studies, it's critical to verify which reference sequence was used to ensure accurate interpretation of results. Despite this numerical difference, antibodies targeting either Ser1231 or Ser1232 are detecting the same phosphorylation site within the protein's structure, just with different position designations based on the reference sequence employed.

What techniques has the Phospho-EIF4G1 (Ser1232) antibody been validated for?

The rabbit polyclonal Phospho-EIF4G1 (Ser1232) antibody has been rigorously validated for multiple experimental techniques specifically with human samples. The primary validated applications include:

• Western Blot (recommended dilution 1:500-1:1000)

• Immunohistochemistry (recommended dilution 1:50-1:100)

• Immunohistochemistry-Paraffin (recommended dilution 1:50-1:100)

The antibody specifically detects endogenous levels of eIF4G1 only when phosphorylated at serine 1232, making it valuable for studying phosphorylation-dependent regulation of translation initiation. When designing experiments, researchers should note that this antibody was produced against a synthesized phosphopeptide derived from human eIF4G1 around the phosphorylation site of serine 1232 (P-V-Sp-P-L), which explains its high specificity for the phosphorylated form of the protein .

How should the Phospho-EIF4G1 (Ser1232) antibody be stored to maintain optimal activity?

Proper storage is critical for maintaining antibody functionality and preventing degradation. For Phospho-EIF4G1 (Ser1232) antibody, the following storage protocols are recommended:

• Short-term storage: Store at 4°C

• Long-term storage: Aliquot and store at -20°C

• Always avoid freeze-thaw cycles, as repeated freezing and thawing can significantly reduce antibody activity

The antibody is typically supplied in PBS (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl and 50% glycerol with 0.02% Sodium Azide . This buffer composition helps maintain stability during storage. When preparing working dilutions, it's advisable to dilute just before use rather than storing diluted antibody solutions for extended periods, as this can lead to reduced sensitivity and increased background.

How does phosphorylation of eIF4G1 at different serine residues affect its function in the eIF4F complex?

Research has identified multiple phosphorylation sites on eIF4G1, including Ser1147, Ser1185, and Ser1231/1232, each regulated by distinct signaling pathways and serving different functional roles:

Interestingly, while all three phosphorylation sites are present in brain tissue under normal and ischemic conditions, only phosphorylation at Ser1147 has been detected in the eIF4E/eIF4G association complex isolated using m7GTP-Sepharose cap-binding assays . This suggests that different phosphorylation patterns may determine which protein complexes eIF4G1 participates in, thereby regulating various aspects of translation initiation. Furthermore, the phosphorylation status of these sites changes differentially under stress conditions, indicating their involvement in stress-responsive translation regulation mechanisms.

What is the role of Phospho-EIF4G1 (Ser1232) in stress conditions such as ischemia-reperfusion?

In the context of cellular stress conditions like ischemia-reperfusion (IR), phosphorylation of eIF4G1 exhibits tissue-specific and site-specific regulation patterns. Research has demonstrated that while phosphorylation at Ser1147, Ser1185, and Ser1231/1232 is present in both resistant (cortical) and vulnerable (hippocampal CA1) brain regions, their regulation differs significantly during stress .

In contrast, phosphorylation at Ser1231/1232, which is regulated by the ERK1/2 pathway, does not appear to be directly associated with the eIF4E/eIF4G complex in brain tissue samples during ischemic conditions . This suggests that eIF4G1 phosphorylated at Ser1231/1232 may participate in alternative protein complexes or pathways during stress, potentially serving functions beyond direct cap-dependent translation initiation.

What controls should be included when using Phospho-EIF4G1 (Ser1232) antibody in Western blot experiments?

Designing rigorous controls for phospho-specific antibody experiments is crucial for accurate interpretation of results. When using Phospho-EIF4G1 (Ser1232) antibody, the following controls should be included:

• Positive control: Lysates from cells treated with agents known to activate ERK1/2 signaling, such as growth factors or phorbol esters, which should increase Ser1232 phosphorylation

• Negative control:

  • Untreated cell lysates (basal phosphorylation)

  • Lysates treated with ERK1/2 pathway inhibitors

  • Lysates treated with lambda phosphatase to remove all phosphorylations

• Specificity control: Use of competing phosphopeptide (P-V-Sp-P-L) to confirm signal specificity

• Loading control: Probing for total eIF4G1 on a parallel blot or after stripping and reprobing

• Molecular weight verification: Confirm that the detected band appears at the expected 220 kDa

When analyzing phosphorylation changes, it's crucial to normalize phospho-eIF4G1 (Ser1232) signal to total eIF4G1 levels to account for changes in protein expression rather than phosphorylation state. Additionally, when studying the eIF4E/eIF4G complex specifically, researchers should consider using m7GTP-Sepharose pulldown assays or co-immunoprecipitation experiments to isolate the complex before probing for phosphorylation status .

How can researchers resolve detection issues when using Phospho-EIF4G1 (Ser1232) antibody in immunohistochemistry?

Immunohistochemical detection of phospho-epitopes presents unique challenges due to epitope masking, phosphatase activity, and fixation effects. To optimize Phospho-EIF4G1 (Ser1232) detection:

• Fixation optimization:

  • Use freshly prepared 4% paraformaldehyde

  • Limit fixation time to prevent overfixation and epitope masking

  • Consider testing alternative fixatives if phospho-epitope detection is problematic

• Antigen retrieval:

  • Heat-induced epitope retrieval with citrate buffer (pH 6.0) or EDTA buffer (pH 8.0)

  • Test multiple retrieval conditions to identify optimal parameters

• Phosphatase inhibition:

  • Include phosphatase inhibitors in all buffers

  • Process tissues rapidly to minimize dephosphorylation

  • Consider post-fixation with phosphatase-inhibiting fixatives

• Signal amplification:

  • Use tyramide signal amplification systems for weak signals

  • Consider polymer detection systems rather than ABC methods

  • Optimize antibody concentration (starting with 1:50-1:100 dilution)

• Background reduction:

  • Extensive blocking with BSA, normal serum, and casein

  • Include 0.1-0.3% Triton X-100 for improved antibody penetration

  • Use of avidin/biotin blocking for tissues with high endogenous biotin

When analyzing results, include parallel sections stained for total eIF4G1 to distinguish changes in phosphorylation from changes in protein localization or expression. Additionally, validation by an orthogonal method like Western blotting is recommended when establishing new immunohistochemical protocols for phospho-specific antibodies.

How can Phospho-EIF4G1 (Ser1232) be used to investigate the relationship between stress-responsive translation and neuronal death?

Recent research has revealed complex relationships between translation regulation and neuronal survival during stress conditions. The phosphorylation state of eIF4G1 at different residues, including Ser1232, provides a molecular window into these processes. Researchers can leverage Phospho-EIF4G1 (Ser1232) antibody to:

• Map temporal phosphorylation dynamics:

  • Track phosphorylation changes at Ser1232 across different timepoints following stress induction

  • Correlate these changes with markers of translation activity (e.g., puromycin incorporation)

  • Compare dynamics between stress-resistant and vulnerable neuronal populations

• Perform spatial analysis of translation regulation:

  • Use immunofluorescence co-localization studies to examine the relationship between Phospho-EIF4G1 (Ser1232) and other translation factors (eIF4E, eIF4A) in different subcellular compartments

  • Compare patterns between healthy neurons and those undergoing stress-induced death

  • Employ super-resolution microscopy to visualize translation complex formation at nanoscale resolution

• Manipulate phosphorylation pathways:

  • Use ERK1/2 pathway modulators to alter Ser1232 phosphorylation status

  • Employ phosphomimetic or phospho-dead eIF4G1 mutants in rescue experiments

  • Correlate phosphorylation status with neuronal survival outcomes

Studies have already demonstrated that in cerebral ischemia models, there are regional differences in eIF4G1 phosphorylation patterns that correlate with vulnerability to ischemic damage . The increased phosphorylation of eIF4G1 at Ser1147 in vulnerable CA1 neurons, coupled with reduced eIF4E/eIF4G1 complex formation, suggests a complex relationship between phosphorylation status and neuronal fate that warrants further investigation using multiple phospho-specific antibodies, including Phospho-EIF4G1 (Ser1232).

How does phosphorylation at Ser1232 interact with other post-translational modifications of eIF4G1 in regulating translation?

Translation regulation involves intricate coordination of multiple post-translational modifications across different initiation factors. Researchers investigating these interactions can utilize Phospho-EIF4G1 (Ser1232) antibody alongside other modification-specific tools to:

• Map the interplay between different phosphorylation sites:

  • Perform sequential immunoprecipitation experiments to determine if Ser1232 phosphorylation co-occurs with phosphorylation at Ser1147 or Ser1185

  • Use phospho-specific antibody arrays to generate comprehensive phosphorylation profiles under different conditions

  • Correlate phosphorylation patterns with functional outcomes using translation reporter assays

• Investigate cross-talk with other modifications:

  • Examine potential interactions between Ser1232 phosphorylation and other modifications like ubiquitination, SUMOylation, or methylation

  • Determine if Ser1232 phosphorylation affects the recognition of eIF4G1 by modifying enzymes for other post-translational modifications

  • Assess whether specific modification patterns create "codes" that direct eIF4G1 to distinct functions

• Explore phosphorylation-dependent protein interactions:

  • Use phospho-specific antibodies in proximity ligation assays to visualize protein interactions dependent on specific phosphorylation states

  • Perform phospho-specific pull-downs followed by mass spectrometry to identify proteins that preferentially interact with eIF4G1 when phosphorylated at Ser1232

  • Compare these interaction networks across different stress conditions or disease models

Current research indicates that different phosphorylation patterns may determine which protein complexes eIF4G1 participates in, with phosphorylation at Ser1147 being associated with the eIF4E/eIF4G complex while Ser1185 and Ser1231/1232 phosphorylation may direct eIF4G1 to alternative complexes . This suggests a "phospho-code" that dynamically regulates eIF4G1 function across different cellular contexts, representing a frontier area for research using phospho-specific antibodies.

How can researchers address the apparent contradiction between increased Ser1147 phosphorylation and decreased eIF4E/eIF4G1 complex formation in vulnerable neurons?

Research has revealed an intriguing paradox in ischemic brain tissue: the vulnerable CA1 region shows both a reduction in eIF4E/eIF4G1 complex formation and a relative increase in Ser1147 phosphorylation within the remaining complex . This apparent contradiction requires careful experimental approaches to unravel:

• Temporal resolution studies:

  • Track both parameters (complex formation and phosphorylation) across finely-spaced timepoints after ischemic insult

  • Determine if these changes occur sequentially rather than simultaneously

  • Use live-cell imaging with fluorescent reporters to visualize dynamics in real-time

• Single-cell analysis:

  • Employ single-cell techniques to determine if the contradiction reflects population heterogeneity

  • Use flow cytometry with intracellular phospho-specific staining to quantify subpopulations

  • Compare patterns between cells at different stages of stress response or cell death

• Functional correlation studies:

  • Correlate phosphorylation patterns with direct measurements of translation activity

  • Use techniques like ribosome profiling or PUNCH-P to assess translation of specific mRNAs

  • Determine if increased phosphorylation in the reduced complex correlates with translation of specific stress-responsive mRNAs

• Pathway inhibition experiments:

  • Use targeted inhibitors of mTOR, PKCα, and ERK1/2 to modify specific phosphorylation events

  • Determine if preventing one phosphorylation event affects the others and/or complex formation

  • Assess if modulating phosphorylation patterns affects neuronal survival outcomes